Insider Trading15 Sept 2026, 04:50 pm
AstraZeneca Pharma India Closes Trading Window
AI Summary
AstraZeneca Pharma India Ltd has announced the closure of its trading window for dealing in the company's equity shares. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The trading window will be shut from September 16, 2026, and will reopen 48 hours after the declaration of the un-audited financial results for the quarter and half-year ending September 30, 2026. This measure is standard practice to prevent insider trading during sensitive financial reporting periods.
Key Highlights
- Trading window closed from September 16, 2026.
- Closure is due to upcoming financial results.
- Window reopens 48 hours post Q2 FY27 results declaration.
- Adheres to SEBI Insider Trading Regulations.
Price Impact
More from ASTRAZEN